General Archive
-
News releasesIndustry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care
London, UK: Novartis UK has launched the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data-driven…
-
News releasesLifeArc appoints Dr Linda Bradley to head up business development
Dr Linda Bradley has joined as our new Head of Business Development, effective immediately.
-
News releasesLifeArc, MRC and BBSRC create £18m network of gene therapy hubs to advance promising research into new treatments for patients
Hubs will be at King’s College London, NHS Blood and Transplant in Bristol and the University of Sheffield
-
News releasesKQ Labs announces the graduation of its third cohort in a highly successful Demo Day event
KQ Labs will be opening its next cohort for applications in early May 2021
-
News releasesLifeArc and Action Medical Research announce commitment of over £1m to research into rare diseases in children
Demonstrates our focus on improving the lives of people living with rare diseases.
-
News releasesRepurposing drugs: the opportunity and the challenges
Sign up for our seminar on intellectual property, regulation, commercial positioning and patient involvement.
-
News releasesLifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19
Medical research charity, LifeArc, announces today that it is providing £5 million funding to support the work of the GenOMICC…
-
News releasesLifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
LifeArc announced today a £10 million cornerstone investment in the funding cycle of Illumina Accelerator Cambridge. This is part of…
-
News releasesLifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children
A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging research that could…
-
News releasesMetrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical…
-
News releasesLifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre…
-
News releasesLifeArc co-leads £6 million funding in DJS Antibodies
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the development of novel…